- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 27.01. | Cheelcare Inc: Cheelcare receives Medicare/Medicaid OK for Companion | 1 | Stockwatch | ||
| 26.01. | Cheelcare Inc.: Cheelcare Announces Medicare and Medicaid Services Reimbursement Approval for Companion Power Assist Device, Expanding U.S. Market Access | 165 | Newsfile | Investment Highlights:U.S. Medicare and Medicaid reimbursement eligibility achieved:The Company has received Pricing, Data Analysis, and Coding ("PDAC") verification, enabling U.S. Medicare and... ► Artikel lesen | |
| 31.12.25 | Cheelcare Inc. GAAP EPS of -$0.03, revenue of $0.39M | 2 | Seeking Alpha | ||
| 30.12.25 | Cheelcare Inc.: Cheelcare Announces Second Quarter Fiscal 2026 Financial Results | 357 | Newsfile | Markham, Ontario--(Newsfile Corp. - December 30, 2025) - Cheelcare Inc. (TSXV: CHER) ("Cheelcare" or the "Company"), a Canadian innovator in advanced mobility solutions, today announced its financial... ► Artikel lesen | |
| 08.12.25 | Cheelcare Inc: Cheelcare reaches 2,000 Companion units sold | 2 | Stockwatch | ||
| 08.12.25 | Cheelcare Inc.: Cheelcare Has a Record Month of Sales and Celebrates Milestone of 2,000 Companions Sold | 217 | Newsfile | Markham, Ontario--(Newsfile Corp. - December 8, 2025) - Cheelcare (TSXV: CHER), a Canadian innovator in advanced mobility solutions, is proud to announce that the Company has reached a major commercial... ► Artikel lesen | |
| 02.12.25 | Cheelcare Inc.: Cheelcare to Represent Canadian Health Innovation at Health Tech Forward 2025 in Barcelona | 255 | Newsfile | Toronto, Ontario--(Newsfile Corp. - December 2, 2025) - Cheelcare (TSXV: CHER), a Canadian innovator in advanced mobility solutions, was selected to participate in a Canadian trade mission to Barcelona... ► Artikel lesen | |
| CHEELCARE Aktie jetzt für 0€ handeln | |||||
| 24.11.25 | Cheelcare Inc: Cheelcare earns Health Canada compliant rating | 2 | Stockwatch | ||
| 17.10.25 | Cheelcare Inc: Cheelcare appoints Jones as director of U.S. sales | 1 | Stockwatch | ||
| 16.10.25 | Cheelcare Inc.: Cheelcare Appoints Dave Jones as Director of U.S. Sales | 270 | Newsfile | Toronto, Ontario--(Newsfile Corp. - October 16, 2025) - Cheelcare Inc. (TSXV: CHER) ("Cheelcare" or the "Company"), a Canadian leader in assistive mobility devices, is pleased to announce the appointment... ► Artikel lesen | |
| 22.09.25 | Cheelcare to Present at the Annual Smallcap Discoveries Conference in Vancouver, British Columbia | 267 | Newsfile | Toronto, Ontario--(Newsfile Corp. - September 22, 2025) - Cheelcare Inc. (TSXV: CHER) ("Cheelcare" or the "Company"), a Canadian leader in assistive mobility devices, today announced its participation... ► Artikel lesen | |
| 16.09.25 | Cheelcare Inc.: Richmond Hill Residents Receive Companion Power Assist Through Foundation Donation | 232 | Newsfile | Richmond Hill, Ontario--(Newsfile Corp. - September 16, 2025) - Cheelcare Inc. (TSXV: CHER) ("Cheelcare" or the "Company"), a Canadian leader in assistive mobility devices, delivered four Companion... ► Artikel lesen | |
| 11.09.25 | Cheelcare Inc.: Cheelcare Turns Heads at the Canadian Seating and Mobility Conference in Toronto | 226 | Newsfile | Toronto, Ontario--(Newsfile Corp. - September 11, 2025) - Cheelcare Inc. (TSXV: CHER) ("Cheelcare" or the "Company"), a Canadian leader in assistive mobility devices, turned heads at the 2025 Canadian... ► Artikel lesen | |
| 26.08.25 | Cheelcare Inc: Cheelcare signs five-year lease for industrial facility | 2 | Stockwatch | ||
| 26.08.25 | Cheelcare Signs Five-Year Lease for New Manufacturing Facility to Support Growth | 1 | CNW | ||
| 24.07.25 | Toronto Stock Exchange: Cheelcare Inc. (CHER) Opens the Market | 449 | Newsfile | Toronto, Ontario--(Newsfile Corp. - July 24, 2025) - Eugene Chery, Chief Executive Officer and Co-Founder, Dima Paltsev, Director and Co-Founder, and Roy Ellis, Director and Chairman, from Cheelcare... ► Artikel lesen |
16 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 41,400 | -2,82 % | DAX-Konzern Siemens Healthineers legt Zahlen vor | Siemens Healthineers startet solide ins neue Geschäftsjahr und bestätigt den Jahresausblick, wird aber vom schwachen Diagnostikgeschäft in China gebremst. Der DAX-Konzern Siemens Healthineers ist mit... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,640 | +0,40 % | Fresenius Medical Care: Ein Neuanfang nach turbulenten Zeiten? | ||
| FRESENIUS | 49,760 | +1,06 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Fresenius mit einem Kursziel von 55 Euro auf "Buy" belassen. Die Bad Homburger seien in Verjüngungskur, und der Markt preise... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 28,740 | +4,89 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 39,680 | +3,44 % | BrightSpring Health Services, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026 | ||
| CARL ZEISS MEDITEC | 27,520 | +0,66 % | ANALYSE-FLASH: Barclays senkt Carl Zeiss Meditec auf 'Equal Weight' | LONDON (dpa-AFX Broker) - Die britische Investmentbank Barclays hat das Kursziel für Carl Zeiss Meditec von 49 auf 32 Euro gesenkt und die Aktien von "Overweight" auf "Equal Weight" abgestuft. Nur... ► Artikel lesen | |
| HEARTFLOW | 27,690 | +6,54 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| GENEDX | 84,35 | +0,32 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 21,990 | +2,23 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| GERRESHEIMER | 25,660 | +1,99 % | JEFFERIES stuft GERRESHEIMER AG auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Gerresheimer mit einem Kursziel von 34,10 Euro auf "Buy" belassen. Analyst James Vane-Tempest zählt den Spezialverpackungshersteller... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,750 | +2,84 % | 6 Analysts Have This To Say About Alignment Healthcare | ||
| PROGYNY | 21,960 | +0,18 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| HIMS & HERS HEALTH | 19,500 | +0,15 % | BREAKING: Hims & Hers verschärft Preisdruck bei Novo Nordisk - Aktie beschleunigt Talfahrt | Der dänische Biopharma-Riese ist erst seit wenigen Wochen mit seinem Appetitzügler Wegovy als Tablette auf dem US-Markt und sieht sich einem massiven Preisdruck ausgesetzt. Das Telehealth-Unternehmen... ► Artikel lesen | |
| UNITEDHEALTH | 232,15 | -0,77 % | UnitedHealth: Das sieht gar nicht gut aus | Der enttäuschende Ausblick, den UnitedHealth dem Kapitalmarkt vor Kurzem an die Hand gegeben hat, und maue Aussichten für 2027 hinterlassen weitere Spuren im Aktienkurs des größten US-Krankenversicherers.... ► Artikel lesen | |
| RXSIGHT | 8,390 | +7,29 % | RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer | ALISO VIEJO, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following... ► Artikel lesen |
CHEELCARE INC gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CHEELCARE INC finden Sie auf Wallstreet Online.